a few months after the genetic test maker filed for bankruptcy. Labcorp expects this transaction would generate approximately $275 million-$300 million in annual revenue, with the majority in ...
Labcorp is in talks with health insurers to see if the test could be covered, Caveney said, adding that it carries a list price of about $240. The test works by measuring four biomarkers ...